Alcon bought Aerie Pharmaceuticals Aerie Pharmaceuticals from 11/22/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Alcon completed its acquisition of Aerie Pharmaceuticals for $770 million, or 15.25 per share.

Aerie Pharmaceuticals

Review

Source:

{source} pictogram

investor.alcon.com

Vladimir Petenev

News editor

Write your comment first

News feed

Fix Price reported for 9 months of 2024

10/31/24 FIXP

Fix Price's LFL sales grew 1.2% in 9 months

10/31/24 FIXP

Sberbank reported for 9 months of 2024 by IFRS

10/31/24 SBER

Moscow Exchange reported for 9 months of 2024 by RAS

10/31/24 MOEX

TGC-14 reported for 9 months of 2024 by RAS

10/31/24 TGKN

Gazprom Neft reports for 9 months of 2024 by RAS

10/31/24 SIBN

Segezha reported for 9 months of 2024 by RAS

10/31/24 SGZH

Seligdar reports for 9 months of 2024 by RAS

10/31/24 SELG

Rusolovo reported for 9 months of 2024 by RAS

10/31/24 ROLO

Globaltrak reported for 9 months of 2024 by RAS

10/31/24 GTRK